The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The Prognostic Significance of Nodal Metastases from Papillary Thyroid Carcinoma Can Be Stratified Based on the Size and Number of Metastatic Lymph Nodes, as Well as the Presence of Extranodal Extension
Abstract
BACKGROUND: Ultrasound and prophylactic dissections have facilitated identification of small-volume cervical lymph node (LN) metastases in patients with papillary thyroid carcinoma (PTC). Since most staging systems do not stratify risk based on size or number of LN metastases, even a single-microscopic LN metastasis can upstage a patient with low-risk papillary thyroid microcarcinoma (PMC) to an intermediate risk of recurrence in the American Thyroid Association (ATA) system and to an increased risk of death in the American Joint Committee on Cancer (AJCC) staging system (stage III if the metastatic node is in the central neck or stage IVA if the microscopic LN metastasis is identified in the lateral neck). Such microscopic upstaging may lead to potentially unnecessary or additional treatments and follow-up studies. The goal of this review is to determine if the literature supports the concept that specific characteristics (clinically apparent size, number, and extranodal extension) of LN metastases can be used to stratify the risk of recurrence in PTC. SUMMARY: In patients with pathological proven cervical LN metastases (pathological N1 disease; pN1), the median risk of loco-regional LN recurrence varies markedly by clinical staging, with recurrence rates for patients who are initially clinically N0 (clinical N0 disease; cN0) of 2% (range 0%-9%) versus rates of recurrence for patients who are initially clinically N-positive (clinical N1 disease; cN1) of 22% (range 10%-42%). Furthermore, the median risk of recurrence in pN1 patients varies markedly by the number of positive nodes, <5 nodes (4%, range 3%-8%) vs. >5 nodes (19%, range 7%-21%). Additionally, the presence of extranodal extension was associated with a median risk of recurrence of 24% (range 15%-32%) and possibly a worse disease-specific survival. CONCLUSION: Our previous paradigm assigned the same magnitude of risk for all patients with N1 disease. However, small-volume subclinical microscopic N1 disease clearly conveys a much smaller risk of recurrence than large-volume, macroscopic clinically apparent loco-regional metastases. Armed with this information, clinicians will be better able to tailor initial treatment and follow-up recommendations. Implications of N1 stratification for PTC into small-volume microscopic disease versus clinically apparent macroscopic disease importantly relate to issues of prophylactic neck dissection utility, need for pathologic nodal size description, and suggest potential modifications to the AJCC TNM (tumor, nodal disease, and distant metastasis) and ATA risk recurrence staging systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Self-citationPapillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
Hay, I. D., Hutchinson, M. E., Gonzalez-Losada, T., McIver, B., Reinalda, M. E., Grant, C. S., Thompson, G. B., Sebo, T. J., & Goellner, J. R. (2008) · Surgery · doi:10.1016/j.surg.2008.08.035 · Cited by 940
Tuttle, R. M., Tala, H., Shah, J., Leboeuf, R., Ghossein, R., Gonen, M., Brokhin, M., Omry, G., Fagin, J. A., & Shaha, A. (2010) · Thyroid · doi:10.1089/thy.2010.0178 · Cited by 924
Ito, Y., Uruno, T., Nakano, K., Takamura, Y., Miya, A., Kobayashi, K., Yokozawa, T., Matsuzuka, F., Kuma, S., Kuma, K., et al. (2003) · Thyroid · doi:10.1089/105072503321669875 · Cited by 877
Wada, N., Duh, Q.-Y., Sugino, K., Iwasaki, H., Kameyama, K., Mimura, T., Ito, K., Takami, H., & Takanashi, Y. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000055273.58908.19 · Cited by 815
Self-citationAn Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients
Ito, Y., Miyauchi, A., Inoue, H., Fukushima, M., Kihara, M., Higashiyama, T., Tomoda, C., Takamura, Y., Kobayashi, K., & Miya, A. (2010) · World Journal of Surgery · doi:10.1007/s00268-009-0303-0 · Cited by 811
Chow, S., Law, S. C. K., Chan, J. K. C., Au, S., Yau, S., & Lau, W. (2003) · Cancer · doi:10.1002/cncr.11442 · Cited by 723
Leboulleux, S., Rubino, C., Baudin, E., Caillou, B., Hartl, D. M., Bidart, J.-M., Travagli, J.-P., & Schlumberger, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0285 · Cited by 588
Sugitani, I., Toda, K., Yamada, K., Yamamoto, N., Ikenaga, M., & Fujimoto, Y. (2010) · World Journal of Surgery · doi:10.1007/s00268-009-0359-x · Cited by 519
Sugitani, I., Kasai, N., Fujimoto, Y., & Yanagisawa, A. (2004) · Surgery · doi:10.1016/s0039-6060(03)00384-2 · Cited by 380
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationCabanillas, M. E., McFadden, D. G., & Durante, C. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30172-6 · Cited by 1,430
Guidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
Shin, J. H., Baek, J. H., Chung, J., Ha, E. J., Kim, J.-H., Lee, Y. H., Lim, H. K., Moon, W.-J., Na, D. G., Park, J. S., et al. (2016) · Korean Journal of Radiology · doi:10.3348/kjr.2016.17.3.370 · Cited by 889
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Self-citationPatel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Self-citationA study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up
Grogan, R. H., Kaplan, S. P., Cao, H., Weiss, R. E., DeGroot, L. J., Simon, C. A., Embia, O. M. A., Angelos, P., Kaplan, E. L., & Schechter, R. B. (2013) · Surgery · doi:10.1016/j.surg.2013.07.008 · Cited by 301
Ha, E. J., Chung, S. R., Na, D. G., Ahn, H. S., Chung, J., Lee, J. Y., Park, J. S., Yoo, R.-E., Baek, J. H., Baek, S. M., et al. (2021) · Korean Journal of Radiology · doi:10.3348/kjr.2021.0713 · Cited by 298
Metadata
- Authors
- Randolph, G. W., Duh, Q.-Y., Heller, K. S., LiVolsi, V. A., Mandel, S. J., Steward, D. L., Tufano, R. P., & Tuttle, F. T. A. T. A.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2012-11
- Volume
- 22
- Issue
- 11
- Pages
- 1144-1152
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1984135618
- Cited by
- 838
- References
- 38
- FWCI
- 32.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.